Clinical trial
STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)
NCT00126360 · St George Hospital, Australia, Other · Unknown status
Key facts
| NCT number | NCT00126360 |
|---|---|
| Title | STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot) |
| Official title | Pilot for a Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Ant-Oestrogen Therapy Delayed Until After Radiotherapy |
| Lead sponsor | St George Hospital, Australia, Other |
| Collaborators | AstraZeneca Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Timing of Anastrozole in respect to radiotherapy |
| Enrollment | 100 |
| Start date | Aug 1, 2005 |
| Completion | May 1, 2016 |
| First posted | Aug 3, 2005 |
| Last update posted | Nov 10, 2005 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: